TCF4 and hepatocellular carcinoma: Other reports have shown that the Wnt antagonists inhibit the growth of HCC cells in vitro and in vivo through inhibition of the formation of the TCF-4/β-catenin complex and its transcriptional activity and downregulation of the β-catenin/TCF-4 target genes c-myc and Survivin [25].